|
|
|
|
|
|
|
29.05.26 - 21:51
|
"Closing The Nuclear Fuel Cycle" - Newcleo′s $780M War Chest And Oklo Partnership Fuel $2.4B SPAC Debut (ZeroHedge)
|
|
|
"Closing The Nuclear Fuel Cycle" - Newcleo's $780M War Chest And Oklo Partnership Fuel $2.4B SPAC Debut
It's open season in the nuclear industry for going public, and this week's episode features newcleo, a European lead-cooled reactor developer.
The Paris-based developer of lead-cooled fast reactors (LFRs) and closed-cycle MOX fuel announced it will merge with NewHold Investment Corp III (ticker NHIC) in a deal valuing the company at roughly $2.4 billion.
A $220 million oversubscribed PIPE at $10 per share plus up to $209 million from the SPAC trust should deliver as much as $429 million in gross proceeds before redemptions and fees. The combined entity expects to list on Nasdaq under ticker NWCL in the second half of 2026.
Hopefully their transition to public markets doesn't follow the same path as microreactor developer Hadron Energy…
Founded by Stefano Buono (the man who took Advanced Accelerator Applications public on Nasdaq in 2015 and sold it to Novartis for $3.9 bil...
|
|
|
|
|
|
|
|
|
29.05.26 - 19:06
|
′Hardware is sexy again′: Plug and Play CEO says AI boom has finally fulfilled his 2006 semiconductor dream (Digitimes)
|
|
|
The building where Saeed Amidi runs his global venture empire was once one of the most important semiconductor facilities on the West Coast. Philips Electronics operated a fabrication plant here in Sunnyvale, California, employing 8,000 people at its peak. Then, like much of America's chip manufacturing base, it moved to Asia — to Taiwan, to Korea, to the supply chains that would come to define the global electronics industry for the next three decades....
|
|
|
|
|
|
|
29.05.26 - 18:32
|
Number of shares and votes in BioArctic AB (publ) as of May 29, 2026 (Cision)
|
|
|
Stockholm, May 29, 2026 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company issued 5,000 Class B shares during May for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 5,000 stock options of series 2019/2028.
As of May 29, 2026, the last trading day of the month, the total number of shares in BioArctic AB amounted to 88,724,485 shares, of which 74,324,489 listed Class B shares and 14,399,996 unlisted Class A shares. The A share has ten...
|
|
|
|
|
|
|
|
|
29.05.26 - 17:33
|
GSK Underweight (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für GSK nach der Analyse aktueller Marktdaten auf "Underweight" mit einem Kursziel von 1700 Pence belassen. Mit Blick auf Trends bei den wichtigsten Biologika- und Praxisprodukten des ......
|
|
|
29.05.26 - 17:33
|
Novo Nordisk Hold (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Novo Nordisk nach einem Gespräch mit einem Rechtsexperten zum Thema GLP-1-Wirkstoffe auf "Hold" mit einem Kursziel von 270 dänischen Kronen belassen. Der Fachmann habe mit ......
|
|
|
|
|
|
|
|
|
|
|
29.05.26 - 16:06
|
New number of shares and votes in Ambea AB (publ) (Cision)
|
|
|
Ambea AB (publ) (“Ambea”) today announces that the number of Ambea shares and votes has changed following (i) senior executives' and key employees' exercise of warrants in the incentive program 2023/2026, and (ii) the cancellation of 4,000,000 shares resolved upon by the Annual General Meeting 2026.
The shares in the incentive program 2023/2026 were issued through the exercise of 283,134 warrants, which entitled to a corresponding number of shares. Through the exercise of the warrants, the number of shares and votes increased by 283,134 and the share capital by SEK 8,258.811609.
After the...
|
|